Actively Recruiting
Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
Led by Thomas Schlöglhofer, PhD, MSc · Updated on 2026-05-08
60
Participants Needed
1
Research Sites
337 weeks
Total Duration
On this page
Sponsors
T
Thomas Schlöglhofer, PhD, MSc
Lead Sponsor
A
Abbott
Collaborating Sponsor
AI-Summary
What this Trial Is About
Left Ventricular Assist Device (LVAD) therapy has become a well-established treatment option for endstage heart-failure either as a bridge to transplant (BTT) or destination therapy (DT). Monitoring of the pump and with this the cardiac status with the HeartMate 3 (HM3) is currently very limited to infrequent log-files with one data entry every 15 minutes and only limited amount of entries. Due to the low resolution data, the standard HM3 monitoring is not feasible for the evaluation of suction events or in depth analysis of the interaction between LVAD and the remaining native heart function. Aim of this study is to develop noninvasive diagnostics of the cardiac remaining respectively recovering function derived from HeartMate 3 pump data only and compare with standard clinical diagnostic procedures. These procedures include cardiac ultrasound and ECG. After this pilot study, the newly developed methods would allow frequent, simple and automatic monitoring of patients implanted with the HeartMate 3 device. Such continuous assessment of cardiac function would massively help therapy optimization of cardiac protection and, if possible, cardiac recovery.
CONDITIONS
Official Title
Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with the HeartMate 3 system implanted at the Medical University of Vienna
- Able and willing to understand and sign the informed consent form
- Do not meet any exclusion criteria
You will not qualify if you...
- Age younger than 18 or older than 75 years
- Unable to provide informed consent
- Known intraventricular or aortic root thrombus formation
- Known pathology of the coagulation system
- Inability to undergo transthoracic ultrasound diagnostics due to poor image quality or inaccessibility
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Vienna
Vienna, Austria, 1090
Actively Recruiting
Research Team
T
Thomas Schlöglhofer, MSc
CONTACT
D
Daniel Zimpfer, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here